Clinical trials: Duodenum Disease

Gastric Ulcer

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

• Completed
• Age: 55 years and older
• Phase 3
• Results posted

Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subjects at risk for developing aspirin-associated gastric ulcers compared to enteric coated (EC) aspirin 325 mg.

Trial name

NCT00960869

Testing

PA32540, EC-Aspirin 325 mg

Where

United States

Volunteers

519 people

Sponsor

POZEN